ipilimumab,nivolumab
bms
[' ipi ', 'nivo', 'melanoma']
next up is dr blank with survival data from prado. neoadjuvant ipi 1 mg/kg +nivo 3 mg/kg followed by index node resection, adjuvant decision based on pathological response. #melanoma #asco22 
Melanoma+Cell Therapy Oncologist @MSKCancerCenter| Cornell/DukeMed/ MGH IM/MSKCC Onc alum | FCOI: https://t.co/kwtet64Pe4